The Marcus (MCS) Registration Filing summary
Event summary combining transcript, slides, and related documents.
Registration Filing summary
16 Dec, 2025Company overview and business model
Operates in lodging and entertainment, with 79 movie theatres (981 screens) in 17 states and seven wholly- or majority-owned hotels and resorts as of June 27, 2024.
Manages nine additional hotels and resorts for third parties, totaling approximately 4,400 rooms.
Headquartered in Milwaukee, Wisconsin, and is the fourth largest theatre circuit in the U.S.
Financial performance and metrics
Reference is made to the most recent Annual Report on Form 10-K and subsequent filings for detailed financials and risk factors.
Use of proceeds and capital allocation
Net proceeds from primary offerings will be used for general corporate purposes, including business expansion, acquisitions, investments, and debt repayment or redemption.
Pending use, proceeds may be invested in short-term investments.
No proceeds will be received from the sale of shares by selling shareholders.
Latest events from The Marcus
- 2025 revenue reached $758.5M with strong theatre and hotel performance and robust growth outlook.MCS
Investor presentation5 Mar 2026 - Both divisions outperformed their industries, with strong revenue growth and a robust 2026 outlook.MCS
Q4 202526 Feb 2026 - Q2 revenue dropped 15%, but hotels outperformed and group bookings surged as theatres rebounded.MCS
Q2 20242 Feb 2026 - Record Q3 revenue, earnings, and industry outperformance with a strengthened capital structure.MCS
Q3 202417 Jan 2026 - Q4 revenue up 16.6% and record hotel results, with strong momentum for 2025 growth.MCS
Q4 202423 Dec 2025 - Annual meeting to vote on directors, incentive plan, executive pay, and auditor ratification.MCS
Proxy Filing2 Dec 2025 - Virtual annual meeting to vote on directors, incentive plan, pay, and auditor ratification.MCS
Proxy Filing2 Dec 2025 - Q1 revenue up 7.4%, but net loss widened to $16.8M; strong outlook for films and hotels.MCS
Q1 202519 Nov 2025 - Q2 2025 revenue up 17%, profit returns, theatres lead growth, CapEx to decline post-2025.MCS
Q2 202516 Nov 2025